MORAYEYE

Serial Number 97911618
606

Registration Progress

Application Filed
Apr 27, 2023
Under Examination
Apr 23, 2024
Approved for Publication
Feb 7, 2024
Published for Opposition
Feb 27, 2024
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: MORAYEYE
Previous Owner: Nanoscope Therapeutics, Inc.
Classes: 005

Trademark Image

MORAYEYE

Basic Information

Serial Number
97911618
Filing Date
April 27, 2023
Published for Opposition
February 27, 2024
Abandonment Date
December 2, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Dec 2, 2024
Classes
005

Rights Holder

Nanoscope Therapeutics, Inc.

03
Address
1312 Brown Trail, STE A
Bedford, TX 76022

Ownership History

Nanoscope Therapeutics, Inc.

Original Applicant
03
Bedford, TX

Nanoscope Therapeutics, Inc.

Owner at Publication
03
Bedford, TX

Legal Representation

Attorney
Alyce Zawacki

Application History

13 events
Date Code Type Description Documents
Dec 2, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Dec 2, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Dec 2, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Dec 2, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Apr 23, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 4, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 27, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 7, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 7, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 25, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 24, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
May 25, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 1, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of retinal diseases

Classification

International Classes
005